2011
DOI: 10.1038/nature10075
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand

Abstract: T helper cells that produce Interleukin-17 (IL-17) (TH17 cells) are a recently identified CD4+ T-cell subset with characterized pathological roles in autoimmune diseases1–3. The nuclear receptors retinoic acid receptor-related orphan receptors α and γt (RORα and RORγt) have indispensible roles in the development of this cell type4–7. Here we present a first-in-class, high-affinity synthetic ligand, SR1001, specific to both RORα and RORγt that inhibits TH17 cell differentiation and function. SR1001 binds specif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
417
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 449 publications
(426 citation statements)
references
References 25 publications
(26 reference statements)
9
417
0
Order By: Relevance
“…Binding of SR1001 results in a conformational change that decreases the affinity of RORa for coactivators and increases its affinity for corepressors, leading to inhibition of RORa activity (35,36). Treatment of SR1001 suppressed pathological retinal neovascularization in the OIR model in our previous study (25).…”
Section: Rora Negatively Regulated Sema3e Promoter-driven Transcriptionmentioning
confidence: 99%
See 3 more Smart Citations
“…Binding of SR1001 results in a conformational change that decreases the affinity of RORa for coactivators and increases its affinity for corepressors, leading to inhibition of RORa activity (35,36). Treatment of SR1001 suppressed pathological retinal neovascularization in the OIR model in our previous study (25).…”
Section: Rora Negatively Regulated Sema3e Promoter-driven Transcriptionmentioning
confidence: 99%
“…RORa regulation of Sema3e transcription was also validated by treatment with a synthetic inverse agonist of RORa/g, SR1001, which can bind directly to the ligandbinding domain of RORa (35,36). Binding of SR1001 results in a conformational change that decreases the affinity of RORa for coactivators and increases its affinity for corepressors, leading to inhibition of RORa activity (35,36).…”
Section: Rora Negatively Regulated Sema3e Promoter-driven Transcriptionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, little is known about the involvement of RORγt in thrombocytopenia and autoimmune hemolytic anemia. Solt et al [33] have reported that synthetic ROR ligand suppresses Th17 differentiation and autoimmunity. These findings suggest that therapy involving the regulation of ROR might be of potential use in the treatment of autoimmune diseases.…”
mentioning
confidence: 99%